Methotrexate - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB503240776

Publication Date:

March 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
The global market for Methotrexate was estimated to be worth US$ 517.2 million in 2023 and is forecast to a readjusted size of US$ 624.6 million by 2030 with a CAGR of 2.7% during the forecast period 2024-2030
North America is the largest Methotrexate market with about 49% market share. China is follower, accounting for about 12% market share.
The key players are Teva Pharmaceutical Industries, Qualitestrx(DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical, Powerdone, Huiyu etc. Top 3 companies occupied about 65% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Methotrexate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Methotrexate by region & country, by Type, and by Application.
The Methotrexate market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate.
麻豆原创 Segmentation
By Company
Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Segment by Type:
Methotrexate for Injection
Methotrexate Tablets
Segment by Application
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Methotrexate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Methotrexate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Methotrexate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Methotrexate Product Introduction
1.2 Global Methotrexate 麻豆原创 Size Forecast
1.2.1 Global Methotrexate Sales Value (2019-2030)
1.2.2 Global Methotrexate Sales Volume (2019-2030)
1.2.3 Global Methotrexate Sales Price (2019-2030)
1.3 Methotrexate 麻豆原创 Trends & Drivers
1.3.1 Methotrexate Industry Trends
1.3.2 Methotrexate 麻豆原创 Drivers & Opportunity
1.3.3 Methotrexate 麻豆原创 Challenges
1.3.4 Methotrexate 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Methotrexate Players Revenue Ranking (2023)
2.2 Global Methotrexate Revenue by Company (2019-2024)
2.3 Global Methotrexate Players Sales Volume Ranking (2023)
2.4 Global Methotrexate Sales Volume by Company Players (2019-2024)
2.5 Global Methotrexate Average Price by Company (2019-2024)
2.6 Key Manufacturers Methotrexate Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Methotrexate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Methotrexate
2.9 Methotrexate 麻豆原创 Competitive Analysis
2.9.1 Methotrexate 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Methotrexate Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methotrexate as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Methotrexate for Injection
3.1.2 Methotrexate Tablets
3.2 Global Methotrexate Sales Value by Type
3.2.1 Global Methotrexate Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Methotrexate Sales Value, by Type (2019-2030)
3.2.3 Global Methotrexate Sales Value, by Type (%) (2019-2030)
3.3 Global Methotrexate Sales Volume by Type
3.3.1 Global Methotrexate Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Methotrexate Sales Volume, by Type (2019-2030)
3.3.3 Global Methotrexate Sales Volume, by Type (%) (2019-2030)
3.4 Global Methotrexate Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Used for Cancers
4.1.2 Used for Rheumatoid Arthritis
4.1.3 Used for Other Diseases
4.2 Global Methotrexate Sales Value by Application
4.2.1 Global Methotrexate Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Methotrexate Sales Value, by Application (2019-2030)
4.2.3 Global Methotrexate Sales Value, by Application (%) (2019-2030)
4.3 Global Methotrexate Sales Volume by Application
4.3.1 Global Methotrexate Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Methotrexate Sales Volume, by Application (2019-2030)
4.3.3 Global Methotrexate Sales Volume, by Application (%) (2019-2030)
4.4 Global Methotrexate Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Methotrexate Sales Value by Region
5.1.1 Global Methotrexate Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Methotrexate Sales Value by Region (2019-2024)
5.1.3 Global Methotrexate Sales Value by Region (2025-2030)
5.1.4 Global Methotrexate Sales Value by Region (%), (2019-2030)
5.2 Global Methotrexate Sales Volume by Region
5.2.1 Global Methotrexate Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Methotrexate Sales Volume by Region (2019-2024)
5.2.3 Global Methotrexate Sales Volume by Region (2025-2030)
5.2.4 Global Methotrexate Sales Volume by Region (%), (2019-2030)
5.3 Global Methotrexate Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Methotrexate Sales Value, 2019-2030
5.4.2 North America Methotrexate Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Methotrexate Sales Value, 2019-2030
5.5.2 Europe Methotrexate Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Methotrexate Sales Value, 2019-2030
5.6.2 Asia Pacific Methotrexate Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Methotrexate Sales Value, 2019-2030
5.7.2 South America Methotrexate Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Methotrexate Sales Value, 2019-2030
5.8.2 Middle East & Africa Methotrexate Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Methotrexate Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Methotrexate Sales Value
6.2.1 Key Countries/Regions Methotrexate Sales Value, 2019-2030
6.2.2 Key Countries/Regions Methotrexate Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Methotrexate Sales Value, 2019-2030
6.3.2 United States Methotrexate Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Methotrexate Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Methotrexate Sales Value, 2019-2030
6.4.2 Europe Methotrexate Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Methotrexate Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Methotrexate Sales Value, 2019-2030
6.5.2 China Methotrexate Sales Value by Type (%), 2023 VS 2030
6.5.3 China Methotrexate Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Methotrexate Sales Value, 2019-2030
6.6.2 Japan Methotrexate Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Methotrexate Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Methotrexate Sales Value, 2019-2030
6.7.2 South Korea Methotrexate Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Methotrexate Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Methotrexate Sales Value, 2019-2030
6.8.2 Southeast Asia Methotrexate Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Methotrexate Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Methotrexate Sales Value, 2019-2030
6.9.2 India Methotrexate Sales Value by Type (%), 2023 VS 2030
6.9.3 India Methotrexate Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Teva Pharmaceutical Industries
7.1.1 Teva Pharmaceutical Industries Company Information
7.1.2 Teva Pharmaceutical Industries Introduction and Business Overview
7.1.3 Teva Pharmaceutical Industries Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Teva Pharmaceutical Industries Methotrexate Product Offerings
7.1.5 Teva Pharmaceutical Industries Recent Development
7.2 Qualitestrx (DAVA Pharmaceuticals)
7.2.1 Qualitestrx (DAVA Pharmaceuticals) Company Information
7.2.2 Qualitestrx (DAVA Pharmaceuticals) Introduction and Business Overview
7.2.3 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Qualitestrx (DAVA Pharmaceuticals) Methotrexate Product Offerings
7.2.5 Qualitestrx (DAVA Pharmaceuticals) Recent Development
7.3 Pfizer (Hospira)
7.3.1 Pfizer (Hospira) Company Information
7.3.2 Pfizer (Hospira) Introduction and Business Overview
7.3.3 Pfizer (Hospira) Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer (Hospira) Methotrexate Product Offerings
7.3.5 Pfizer (Hospira) Recent Development
7.4 Roxane Laboratories
7.4.1 Roxane Laboratories Company Information
7.4.2 Roxane Laboratories Introduction and Business Overview
7.4.3 Roxane Laboratories Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Roxane Laboratories Methotrexate Product Offerings
7.4.5 Roxane Laboratories Recent Development
7.5 Sine
7.5.1 Sine Company Information
7.5.2 Sine Introduction and Business Overview
7.5.3 Sine Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sine Methotrexate Product Offerings
7.5.5 Sine Recent Development
7.6 Maoxiang
7.6.1 Maoxiang Company Information
7.6.2 Maoxiang Introduction and Business Overview
7.6.3 Maoxiang Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Maoxiang Methotrexate Product Offerings
7.6.5 Maoxiang Recent Development
7.7 LingNan Pharmaceutical
7.7.1 LingNan Pharmaceutical Company Information
7.7.2 LingNan Pharmaceutical Introduction and Business Overview
7.7.3 LingNan Pharmaceutical Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.7.4 LingNan Pharmaceutical Methotrexate Product Offerings
7.7.5 LingNan Pharmaceutical Recent Development
7.8 Powerdone
7.8.1 Powerdone Company Information
7.8.2 Powerdone Introduction and Business Overview
7.8.3 Powerdone Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Powerdone Methotrexate Product Offerings
7.8.5 Powerdone Recent Development
7.9 Huiyu
7.9.1 Huiyu Company Information
7.9.2 Huiyu Introduction and Business Overview
7.9.3 Huiyu Methotrexate Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Huiyu Methotrexate Product Offerings
7.9.5 Huiyu Recent Development
8 Industry Chain Analysis
8.1 Methotrexate Industrial Chain
8.2 Methotrexate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Methotrexate Sales Model
8.5.2 Sales Channel
8.5.3 Methotrexate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Teva Pharmaceutical Industries
Qualitestrx (DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.